Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Germany’s Merck Makes Progress in New Acquisition

By Drug Discovery Trends Editor | February 6, 2014

Merck announced that shareholders representing 56.48% of the share capital of AZ Electronic Materials (AZ) had accepted Merck’s recommended cash offer for the company. 
 
On Dec. 5, 2013, Merck announced that it was offering GBpence 403.5 per share of AZ in cash, with the successful completion of the transaction being conditional, among others, upon antitrust clearances as well as a minimum acceptance level of 95% of the share capital. Merck also extended the offer period to Feb. 18. 
 
Merck also announced that in addition to the U.S. antitrust clearance announced on Jan. 23, in the meantime the German Federal Cartel Office has granted early clearance with effect from Feb. 5 and the Taiwan Fair Trade Commission has granted early clearance with effect from Jan. 24.
 
All other antitrust filings have been initiated and are proceeding in the normal course, including in China where Phase 1 of the review by the Ministry of Commerce of the People’s Republic of China was initiated on Jan. 29 and will end on Feb. 28. 
 
Date: February 6, 2014
Source: Merck KGaA

Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE